The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and Have patients been harmed by unsafe drug compounding? Partnership for Safe Medicines Mitigating Risks of Compounded Drugs Through Surveillance FDA Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law